alendronate has been researched along with Lymphoma in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jensen, P | 1 |
| Jakobsen, LH | 1 |
| Bøgsted, M | 1 |
| Baech, J | 1 |
| Lykkeboe, S | 1 |
| Severinsen, MT | 1 |
| Vestergaard, P | 1 |
| El-Galaly, TC | 1 |
1 trial available for alendronate and Lymphoma
| Article | Year |
|---|---|
A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment.
Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Female; Glucocorticoids; Humans; Lympho | 2022 |